EVITA Dengue: a cluster-randomized controlled trial to EValuate the efficacy of Wolbachia-InfecTed Aedes aegypti mosquitoes in reducing the incidence of Arboviral infection in Brazil
DiscussionDMID 17-0111 aims to determine the efficacy ofWolbachia-infected mosquito releases in reducing human infections by arboviruses transmitted byAedes aegypti and will complement the mounting evidence for this method from large-scale field releases and ongoing trials. The trial also represents a critical step towards robustness and rigor for how vector control methods are assessed, including the simultaneous measurement and correlation of entomologic and epidemiologic outcomes. Data from this trial will inform further the development of novel vector control methods.Trial registrationClinicalTrials.govNCT04514107. Reg...
Source: Trials - March 2, 2022 Category: Research Source Type: clinical trials
Barom ètre Santé Adulte 2021-2022
Conditions: Diabetes; Hypercholesterolemia; Renal Failure; Dengue Fever; Zika; Chikungunya; Ross River; Malaria; SARS-CoV Infection; Chronic Disease Intervention: Biological: Blood sample Sponsors: Agence Sanitaire et Sociale de Nouvelle Calédonie; Institut Pasteur; Pacific Community; World Health Organization; Institut de la Statitique et des Etudes Economiques Nouvelle Calédonie Suspended (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 1, 2022 Category: Research Source Type: clinical trials
